Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model 2025-08-13 07:00
Mabwell Announces First Patient Dosed in the US Clinical Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated with ADCs 2025-08-12 22:00
Massimo Motor Expands Sales Network into Oregon and Arkansas, Adding Over 100 Locations 2025-08-12 20:30
ReTo RT18A Production Line Wins Favor of UAE Client and Successfully Ships 2025-08-12 20:00
Daqo New Energy to Announce Unaudited Results for the Second Quarter of 2025 on August 26, 2025 2025-08-12 19:00
Tencent Music Entertainment Group Announces Second Quarter 2025 Unaudited Financial Results 2025-08-12 17:00
HUYA Inc. Reports Second Quarter 2025 Unaudited Financial Results 2025-08-12 16:30
ChipMOS REPORTS SECOND QUARTER 2025 RESULTS 2025-08-12 15:00
Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million 2025-08-12 09:36
Yalla Group Limited Announces Unaudited Second Quarter 2025 Financial Results 2025-08-12 05:00
Ucommune Announces Extraordinary General Meeting 2025-08-12 04:00
Xiao-I Corporation Celebrates Eight Consecutive Years Empowering Premium Kitchen Appliance Leader with AI-Driven Customer Experience 2025-08-11 21:15
AMI Pharm Advances AYP-101 to Phase 3, Paving the Way for a New Era in Fat-Reduction Injectable drugs 2025-08-11 20:00
Tuya to Report Second Quarter 2025 Financial Results on August 26, 2025 Eastern Time 2025-08-11 18:00
OneConnect to Announce First Half 2025 Financial Results 2025-08-11 18:00
NWTN and Pakistan's JW Corporation Enter New Energy Commercial Vehicle Production Partnership, Implementing "UAE HQ + South Asia Manufacturing + Global Sales" Strategy 2025-08-11 18:00
FinVolution Group to Report Second Quarter 2025 Financial Results on Wednesday, August 20, 2025 2025-08-11 17:45
Gaotu Techedu to Report Second Quarter 2025 Financial Results on August 26, 2025 2025-08-11 17:00
Akeso Announces First Patient Dosed in Phase III Trial of Ivonescimab as Consolidation Therapy for Limited-Stage SCLC After Definitive Radiotherapy 2025-08-11 10:52
Hugel launches botulinum toxin Letybo in Malaysia 2025-08-11 08:30